Suchergebnisse - (Subject:"Drug repurposing")

PubPharm (150)

1

Exploring a repurposed candidate with dual hIDO1/hTDO2 inhibitory potential for anticancer efficacy identified through pharmacophore-based virtual screening and in vitro evaluation

enthalten in: Scientific reports | 2024

von Aboomar, N. | Essam, O. | Hassan, A. | +2

2

Drug repurposing-based nanoplatform via modulating autophagy to enhance chemo-phototherapy against colorectal cancer

enthalten in: Journal of nanobiotechnology | 2024

von Ding, K. | Tian, H. | Li, L. | +8

3

Comprehensive review of the repositioning of non-oncologic drugs for cancer immunotherapy

enthalten in: Medical oncology (Northwood, London, England) | 2024

von Rauf, A. | Joshi, P. | Olatunde, A. | +9

4

Dual Drug Repurposing : The Example of Saracatinib

enthalten in: International journal of molecular sciences | 2024

von Ramos, R. | Vale, N.

5

Codelivery of ivermectin and methyl dihydrojasmonate in nanostructured lipid carrier for synergistic antileukemia therapy

enthalten in: International journal of pharmaceutics | 2024

von Abou-Elnour, F. | El-Habashy, S. | Essawy, M. | +1

6

Selection of clinically relevant drug concentrations for in vitro studies of candidates drugs for cancer repurposing : a proposal

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Robles-Bañuelos, B. | Romo-Perez, A. | Dominguez-Gomez, G. | +3

7

Targeting autophagy by antipsychotic phenothiazines : potential drug repurposing for cancer therapy

enthalten in: Biochemical pharmacology | 2024

von Lopes, R. | Souza, A. | Otręba, M. | +3

8

Eravacycline, an antibacterial drug, repurposed for pancreatic cancer therapy : insights from a molecular-based deep learning model

enthalten in: Briefings in bioinformatics | 2024

von Jabarin, A. | Shtar, G. | Feinshtein, V. | +4

9

Identification of Fasudil as a collaborator to promote the anti-tumor effect of lenvatinib in hepatocellular carcinoma by inhibiting GLI2-mediated hedgehog signaling pathway

enthalten in: Pharmacological research | 2024

von Huang, Y. | Wang, S. | Zhang, X. | +6

10

Repurposing of FDA approved kinase inhibitor bosutinib for mitigation of radiation induced damage via inhibition of JNK pathway

enthalten in: Toxicology and applied pharmacology | 2024

von Singh, B. | Patwardhan, R. | Pal, D. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]